Neurotransmitter antagonism in management of irritable bowel syndrome.
作者信息
Lembo T
机构信息
Department of Medicine, Harvard Medical School Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
出版信息
Lancet. 2000 Mar 25;355(9209):1030-1. doi: 10.1016/S0140-6736(00)02028-6.
Abstract
摘要
相似文献
1
Neurotransmitter antagonism in management of irritable bowel syndrome.
Lancet. 2000 Mar 25;355(9209):1030-1. doi: 10.1016/S0140-6736(00)02028-6.
2
Irritable bowel syndrome and the role of 5-HT. Proceedings of a roundtable meeting. New Orleans, Louisiana, USA. May 1998.肠易激综合征与5-羟色胺的作用。一次圆桌会议的会议记录。美国路易斯安那州新奥尔良。1998年5月。
Aliment Pharmacol Ther. 1999 May;13 Suppl 2:1-82.
3
Alosetron for irritable bowel syndrome.
Lancet. 2000 Dec 9;356(9246):2009-10. doi: 10.1016/S0140-6736(05)72978-0.
4
Alosetron: a new therapy for irritable bowel syndrome.
Nurse Pract. 2000 Jul;25(7):95-6, 98-100.
5
[Soon one "female distress" less. Irritable bowel syndrome responds to serotonin blockers].
MMW Fortschr Med. 2000 Sep 14;142(37):55.
6
[New therapeutic approaches in irritable bowel syndrome].
Z Gastroenterol. 2000 Sep;38(9):815-6. doi: 10.1055/s-2000-10945.
7
[Irritable bowel syndrome: diagnostic criteria and recent advancement of its pharmacological management].
Nihon Shokakibyo Gakkai Zasshi. 2001 Oct;98(10):1146-53.
8
Alosetron in irritable bowel syndrome.
Lancet. 2000 Jul 8;356(9224):164-5. doi: 10.1016/S0140-6736(05)73177-9.
9
Alosetron (Lotronex) for treatment of irritable bowel syndrome.
Med Lett Drugs Ther. 2000 Jun 26;42(1081):53-4.
10
New drugs to treat irritable bowel syndrome being tested.
Mayo Clin Health Lett. 2000 Mar;18(3):4.
Zotero 插件